---
figid: PMC3913495__BMRI2014-698313.001
figtitle: IL-6 exerts its pleiotropic activity by activation of gp130 through its
  binding to transmembrane or soluble IL-6 receptor
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC3913495
filename: BMRI2014-698313.001.jpg
figlink: /pmc/articles/PMC3913495/figure/fig1/
number: F1
caption: 'IL-6 exerts its pleiotropic activity by activation of gp130 through its
  binding to transmembrane or soluble IL-6 receptor. IL-6 initiates the IL-6 signaling
  pathway through binding to transmembrane or soluble IL-6 receptor. The resultant
  complex then induces homodimerization of gp130, which leads to activation of a signaling
  system. Transcriptional factors including STAT3 activate various gene expressions,
  resulting in cell differentiation or proliferation. JAKs: Janus kinases; STAT3:
  signal transducer and activator of transcription 3; SHP-2: SH2 domain-containing
  tyrosine phosphatase 2; PI3K: phosphoinositol-3 kinase; Grb2, growth factor receptor-bound
  protein 2; ERK: extracellular signal-regulated kinase; MAPK: mitogen activated protein
  kinase; Akt: protein kinase B; TGF-β: transforming growth factor beta; CRP: C-reactive
  protein; SAA: serum amyloid A; MMPs: matrix metalloproteinases.'
papertitle: Interleukin 6 and Rheumatoid Arthritis.
reftext: Yuji Yoshida, et al. Biomed Res Int. 2014;2014:698313.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9324959
figid_alias: PMC3913495__F1
figtype: Figure
redirect_from: /figures/PMC3913495__F1
ndex: 5e83f181-dedf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3913495__BMRI2014-698313.001.html
  '@type': Dataset
  description: 'IL-6 exerts its pleiotropic activity by activation of gp130 through
    its binding to transmembrane or soluble IL-6 receptor. IL-6 initiates the IL-6
    signaling pathway through binding to transmembrane or soluble IL-6 receptor. The
    resultant complex then induces homodimerization of gp130, which leads to activation
    of a signaling system. Transcriptional factors including STAT3 activate various
    gene expressions, resulting in cell differentiation or proliferation. JAKs: Janus
    kinases; STAT3: signal transducer and activator of transcription 3; SHP-2: SH2
    domain-containing tyrosine phosphatase 2; PI3K: phosphoinositol-3 kinase; Grb2,
    growth factor receptor-bound protein 2; ERK: extracellular signal-regulated kinase;
    MAPK: mitogen activated protein kinase; Akt: protein kinase B; TGF-β: transforming
    growth factor beta; CRP: C-reactive protein; SAA: serum amyloid A; MMPs: matrix
    metalloproteinases.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tgfb1
  - Ltbp1
  - Il6
  - Cd4
  - Crp
  - Dmbt1
  - Crip2
  - Saa
  - Stat3
  - Ptpn11
  - Grb2
  - Akt1
  - ras
  - Hras
  - Kras
  - Rem1
  - Ephb2
  - Mapk1
  - Il1
  - TGFB1
  - TGFB2
  - TGFB3
  - IL6
  - CD4
  - CRP
  - CSRP1
  - PPIAP10
  - SAA1
  - SAA2
  - SAA4
  - FGA
  - FGB
  - FGG
  - STAT3
  - PTPN11
  - GRB2
  - AKT1
  - AKT2
  - AKT3
  - KRAS
  - HRAS
  - NRAS
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - IL1B
  - il6
  - kita
  - ngfra
  - ighv1-1
  - cd4-1
  - crp
  - crp4
  - apcs
  - crp7
  - saa
  - stat3
  - ptpn11a
  - grb2b
  - rab1ab
---
